Ryan D Maynard's Net Worth
Ryan D Maynard's net worth is estimated to be at least $392,908.64 as of 11/09/2024. CoreStreet's estimation of Ryan D Maynard's net worth is based on their sale of stock and current holding of stock.
Ryan D Maynard is CFO at Cara Therapeutic. They have executed at least 2 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,488 units of CARA stock on 02/08/2024. Their biggest sale was on 11/03/2017 when they sold 100,000 units of Rigel Pharmaceuticals Inc stock for $390,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $392,908.64
Most recent insider trade:
- Feb. 8, 2024
Ryan D Maynard's Insider Trading History
| Cara Therapeutic | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 8, 2024 | CFO | 5,488 | $0.53 | Sell | $2,908.64 |
| Rigel Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 3, 2017 | CFO | 100,000 | $3.90 | Sell | $390,000.00 |